Cruz, N.; Herculano-Carvalho, M.; Roque, D.; Faria, C.C.; Cascão, R.; Ferreira, H.A.; Reis, C.P.; Matela, N.
Highlighted Advances in Therapies for Difficult-To-Treat Brain Tumours Such as Glioblastoma. Pharmaceutics 2023, 15, 928.
https://doi.org/10.3390/pharmaceutics15030928
AMA Style
Cruz N, Herculano-Carvalho M, Roque D, Faria CC, Cascão R, Ferreira HA, Reis CP, Matela N.
Highlighted Advances in Therapies for Difficult-To-Treat Brain Tumours Such as Glioblastoma. Pharmaceutics. 2023; 15(3):928.
https://doi.org/10.3390/pharmaceutics15030928
Chicago/Turabian Style
Cruz, Nuno, Manuel Herculano-Carvalho, Diogo Roque, Cláudia C. Faria, Rita Cascão, Hugo Alexandre Ferreira, Catarina Pinto Reis, and Nuno Matela.
2023. "Highlighted Advances in Therapies for Difficult-To-Treat Brain Tumours Such as Glioblastoma" Pharmaceutics 15, no. 3: 928.
https://doi.org/10.3390/pharmaceutics15030928
APA Style
Cruz, N., Herculano-Carvalho, M., Roque, D., Faria, C. C., Cascão, R., Ferreira, H. A., Reis, C. P., & Matela, N.
(2023). Highlighted Advances in Therapies for Difficult-To-Treat Brain Tumours Such as Glioblastoma. Pharmaceutics, 15(3), 928.
https://doi.org/10.3390/pharmaceutics15030928